Novo Nordisk A/S ADR buy StockNews.com
Start price
14.12.24
/
50%
€102.50
Target price
14.12.25
-
Performance (%)
-58.15%
End price
15.12.25
€42.90
Summary
This prediction ended on 15.12.25 with a price of €42.90. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR performed very badly with a performance of -58.15%. Dividends of €1.10 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 3.278% | 3.278% | -24.933% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten